COVID-19 Pharmacological Management
Empiric Antivirals

Empiric Antivirals


When there is ongoing local circulation of influenza, empiric therapy with neuraminidase inhibitor should be considered for the treatment of influenza virus

Should be adjusted to renal function and stopped as soon as influenza swab is negative

HIV Protease Inhibitors

Lopinavir/ritonavir or other HIV protease inhibitors should not be used because of unfavorable pharmacodynamics and negative clinical trial data